Skip to main content
Ajooni Biotech Limited logo

Ajooni Biotech Limited — Investor Relations & Filings

Ticker · AJOONI ISIN · INE820Y01021 LEI · 335800OAKJWKHF49O339 National Stock Exchange of India Manufacturing
Open in API
Filings indexed 562 across all filing types
Latest filing 2025-02-03 Declaration of Voting R…
Country IN India
Listing National Stock Exchange of India AJOONI

About Ajooni Biotech Limited

https://www.ajoonibiotech.com

Ajooni Biotech Limited specializes in the production and distribution of animal healthcare solutions and nutritional supplements. The company focuses on the livestock sector, offering a comprehensive range of products including compounded cattle feed, mineral mixtures, and specialized supplements formulated to enhance milk productivity and overall animal health. Its portfolio features calcium supplements, liver tonics, and digestive aids designed to meet the specific nutritional needs of dairy animals. The company utilizes research-driven formulations and quality-controlled manufacturing processes to provide effective solutions for livestock management. By prioritizing animal welfare and productivity, it supports the operational efficiency of dairy farming through scientifically developed nutritional interventions.

Recent filings

Filing Released Lang Actions
Shareholders meeting
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a detailed communication from Ajooni Biotech Limited regarding the outcome and proceedings of the 1st Extra Ordinary General Meeting (EGM) held on February 3, 2025. It includes the agenda items discussed, such as alteration of Articles of Association, increase in authorized share capital, issuance of convertible warrants, and appointment of an independent director. It also describes the voting process, quorum, and mentions the appointment of a scrutinizer for e-voting. The document is not a full financial report, audit report, or earnings release. It is not a proxy solicitation or a remuneration report. It is a formal announcement of the results and proceedings of an EGM, which fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA). The document length (7383 characters) and content confirm it is not merely a brief announcement or a report publication notice but a substantive disclosure of meeting outcomes and voting results. Therefore, the correct classification is DVA with high confidence.
2025-02-03 English
Updates
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a letter addressed to the National Stock Exchange of India regarding the issuance of a corrigendum to the notice of the 1st Extra Ordinary General Meeting (EGM) scheduled for January 3, 2025. It discusses corrections and clarifications to the explanatory statement related to a preferential allotment of convertible warrants. The document does not contain financial statements or detailed financial data but is an announcement related to a shareholder meeting notice. It is not the notice itself but a corrigendum to the notice. Therefore, it fits best under the category of Proxy Solicitation & Information Statement (PSI), which includes materials sent to shareholders to provide information and request votes for meetings, including corrigenda to such notices.
2025-01-28 English
Updates
Regulatory Filings Classification · 95% confidence The document is a detailed communication from Ajooni Biotech Limited addressed to the National Stock Exchange of India regarding the publication of a corrigendum in newspapers related to the notice of the 1st Extra Ordinary General Meeting (EGM). It includes references to newspaper advertisements, corrigendum notices, and meeting details. There is no indication of financial statements, audit results, earnings data, or management discussion. The document is primarily an announcement about the publication of a corrigendum notice for an EGM, which fits the category of a Regulatory Filing (RNS) as it is a general regulatory announcement and does not fit into more specific categories like AGM Information or Declaration of Voting Results. The document length is substantial but the content is focused on regulatory communication rather than a report or presentation.
2025-01-28 English
Updates
Regulatory Filings Classification · 95% confidence The document is a formal letter addressed to the National Stock Exchange of India, notifying a regulatory change regarding the maintenance location of the company's books of accounts. It references compliance with SEBI Listing Obligations and Disclosures Requirements Regulations, 2015, and Section 128 of the Companies Act, 2013. The content is an intimation or announcement of a corporate administrative change rather than a financial report, audit, or management discussion. The document length is short (1703 characters), and it serves as a regulatory notification. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2025-01-25 English
Updates
Regulatory Filings Classification · 95% confidence The document is a letter addressed to the National Stock Exchange of India Limited, dated January 20, 2025, from Ajooni Biotech Limited. It announces the appointment of over 300 dealers and distributors across India, expansion into the B2C market, and strategic initiatives such as backward integration and veterinary expert involvement. The content focuses on business expansion, distribution network growth, and product strategy rather than financial results, regulatory compliance, or governance changes. The document length is 3882 characters, which is relatively short and reads like a business update or announcement rather than a detailed financial or regulatory report. There is no mention of financial statements, audit results, voting outcomes, or executive changes. It is not a report publication announcement since it does not mention any report being attached or published. The document is best classified as a general regulatory announcement about business operations and expansion, fitting the Regulatory Filings (RNS) category as a fallback for miscellaneous filings that do not fit other specific categories.
2025-01-20 English
Updates
Regulatory Filings Classification · 95% confidence The document is a confirmation certificate submitted pursuant to Regulation 74(5) of the Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018, for the quarter ended December 31, 2024. It is a certificate issued by the Registrar and Transfer Agent (RTA) confirming dematerialisation activities and compliance with regulatory requirements. The document is short (2827 characters) and serves as a regulatory compliance certificate rather than a financial report or announcement of financial results. It does not contain financial statements, management discussion, or other report content. Therefore, it fits best under Regulatory Filings (RNS), which covers officer certifications, attestations, and miscellaneous regulatory documents that do not fit other categories.
2025-01-14 English

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.